White Rock intercepts new massive sulphide mineralisation

|

Published 20-JUN-2018 13:07 P.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

White Rock Minerals (ASX:WRM) today released results from its orientation geophysics work.

Orientation geophysics at WRM’s 100% owned high-grade zinc VMS project at its Red Mountain Project in Alaska has confirmed that the Dry Creek massive sulphide mineralisation is coincident with strong conductivity anomalies.

These anomalies were identified using both the CSAMT geophysics exploration tool and time domain electromagnetics geophysics.

The Red Mountain Project contains polymetallic VMS mineralisation rich in zinc, silver and lead, with potential for significant gold and copper. Mineralisation occurs from surface and is open along strike and down-dip.

The project has an Inferred JORC 2012 Mineral Resource estimate for the Dry Creek and West Tundra Flats deposit that contains an impressive base metal and precious metal content with 678,000t zinc, 286,000t lead, 53.5 million ounces silver and 352,000 ounces gold.

Drilling to test for down dip extensions at the Dry Creek zinc VMS deposit intersects massive sulphide mineralisation at the Discovery lens.

The orientation geophysics confirms strong conductivity anomalies are coincident with massive sulphide mineralisation. This successful orientation work has encouraged WRM to progress applying the more rapid acquisition of CSAMT data across priority target areas, prior to drill testing.

At the same time, it’s worth noting that this is an early stage play and investors should seek professional financial advice if considering this company for their portfolio.

At Dry Creek, the first drill hole (DC18-79) at the Discovery zone targeted the down-dip extension of the Resource. Drilling intersected massive sulphide mineralisation with abundant sphalerite (zinc), pyrite and galena (lead) from 230.6 to 236.7 metres downhole. This hole is some 60 metres from the nearest hole (DC97-26).

The image below is of the Dry Creek prospect showing surface projection of massive sulphide mineralisation lens’ and the location of DC18-79 with respect to all historic drill hole traces and the orientation CSAMT line on the DGGS geology map.

Here you can see the coincidence of the CSAMT conductivity anomaly with massive sulphide mineralisation intersected in historic drill holes at the Discovery lens:

Drill hole DC18-79 intersected the massive sulphide zone of abundant sphalerite and galena in the core of the CSAMT anomaly. The coincidence of conductivity and massive sulphide mineralisation rich in sphalerite provides confidence in applying the CSAMT technique to define other targets for drill testing in new prospective areas prioritised by favourable geological observations and anomalous surface geochemistry.

White Rock MD and CEO Matt Gill said, “We are delighted with the results of the orientation geophysics. The stark conductivity anomaly results seen and their coincidence with known massive sulphide mineralisation gives White Rock a powerful exploration tool with which to identify new targets for drill testing, hopefully leading to resource expansion and the discovery of new deposits.

“Further, this latest drill hole intercept of massive sulphides supports our belief that there is further potential for the discovery of more high-grade VMS mineralisation and that this resource is also open down-dip.”



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X